# Autolus Therapeutics plc: Form 8-K, filed Aug 3, 2026

- Company: [Autolus Therapeutics plc](/companies/autl.md) (CIK 1730463)
- Form: 8-K
- Filed: 2026-08-03
- Accepted by EDGAR: Aug 3, 2026, 07:00 ET
- Period: 2026-07-30
- Accession: 0001193125-26-329526
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1730463/000119312526329526/d156965d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1730463/000119312526329526/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 3.02: Unregistered sale of equity
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1730463/000119312526329526/d156965d8k.htm

Filed Aug 3, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-329526. Last ingested by Listed: Nov 14, 2026, 19:20 ET. No prices; not investment advice.
